Cervical Dysplasia Diagnostic Market By Type (Diagnostic Test, Diagnostic Device) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025
Cervical carcinoma accounts for around 15% of all cancers diagnosed in women. Approximately 5 lakhs new cases of cervical cancer in women are observed annually, of which 80% occur in developing countries. Cervical dysplasia is a major health problem among women especially in developing countries with rising incidence of cancer. It is detected in women in their 20’s and peak incidence ranges between 25-35 years, while incidence of cervical cancer rises after 40 years. With rising awareness about cervical dysplasia, improvement in screening technology has led to early diagnosis and treatment to further avoid progression of disease. WHO along with national government are making efforts to build national cancer strategies based on the local need for early treatment and prevention of disease which would help in growth of cervical dysplasia diagnostic market.
The report titled “Cervical Dysplasia Diagnostic Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall cervical dysplasia diagnostic market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on diagnosis type and different geographies.
Geographically, the global cervical dysplasia diagnostic market is studied for the following regional markets:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year. Further cross-sectional presented in terms of diagnosis type and constituent region/country level markets is also included in this section.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global cervical dysplasia diagnostic market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global cervical dysplasia diagnostic market. This report concludes with company profiles section that highlights major information about the key players engaged in global cervical dysplasia diagnostic market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.
Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the cervical dysplasia diagnostic market. The key players profiled in this report are Abbott Laboratories, Becton, Dickinson and company, F. Hoffmann La-Roche Ltd., GlaxoSmithKline Plc, Helix BioPharma Corp., Hologic, Inc., Inovio Biomedical Corporation, Micromedic Technologies Ltd., OncoHealth Corporation, PDS Biotechnology Corporation, Photocure ASA, Quest Diagnostics, Inc., QIAGEN N.V. and others.
Based on the type of diagnosis, the global cervical dysplasia diagnostic market is segmented as follows:
- Diagnostic Test
- HPV Test
- Pap Smear Test
- Biopsy
- Diagnostic Device
- Colposcopy
Diagnostic tests segment occupies the largest share, thus dominating the cervical dysplasia diagnostic market. With advancement in diagnostic technology, awareness about cervical dysplasia, there is rise in screening programs for early diagnosis and treatment of the disease that contribute to the growth of diagnostic test segment of cervical dysplasia diagnostic market. The Pap smear test is the most common, simple and painless test used for detecting cervical dysplasia. However, due to error in the result of almost 15-25% cases, other tests such as HPV is being aggressively used. HPV testing market is anticipated to grow fast in the forecast period due to advancement in technology and preference over Pap smear test due to false negative results. Diagnostic devices such as colposcopes are used if the cervical cells are distinctly abnormal.
For the purpose of this study, the global cervical dysplasia diagnostic market is geographically categorized into:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
In 2016, North America dominated the global cervical dysplasia diagnostic market followed by Europe. Annually around 250,000 to 1 million women in the U.S. are diagnosed with cervical dysplasia. Rising prevalence of various sexually transmitted diseases (STDs), adoption of unhealthy life style such as drinking, smoking and drugs are some of the major reason for cervical dysplasia. There is increase in awareness about occurrence and progress of cervical dysplasia, rise in government funds for screening program, continuously evolving diagnostics technology, favorable reimbursement policies are some of key factors contributing to growth of cervical dysplasia diagnostic market. Asia Pacific is anticipated to be the fastest growing regional market in the forecast period 2017-2025.
Rise in prevalence of cervical cancer, increasing investment for development of healthcare, awareness about cervical cancer, novel diagnostic and treatment options are the key driving factors for cervical dysplasia. With increase in mortality associated with cervical cancer, government funded many screening program are initiated for early diagnosis and treatment to improve the quality of life in developing countries. Emerging economies such as China and India are expected to be lucrative market in the forecast period.
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Cervical Dysplasia Diagnostic Market Portraiture
2.1.1. Global Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2016
2.1.2. Global Cervical Dysplasia Diagnostic Market, by Geography, 2016
Chapter 3. Cervical Dysplasia Diagnostic: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global Cervical Dysplasia Diagnostic Market, by Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Cervical Dysplasia Diagnostic Market, by Type
4.3. Diagnostic Test
4.3.1. HPV Test
4.3.2. Pap Smear Test
4.3.3. Biopsy
4.4. Diagnostic Device
4.4.1. Colposcopy
Chapter 5. Global Cervical Dysplasia Diagnostic Market, by Geography, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. North America Cervical Dysplasia Diagnostic Market Analysis, 2015 – 2025
5.2.1. North America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
5.2.2. North America Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.2.2.1. U.S.
5.2.2.1.1. U.S. Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.2.2.2. Canada
5.2.2.2.1. Canada Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.3. Europe Cervical Dysplasia Diagnostic Market Analysis, 2015 – 2025
5.3.1. Europe Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
5.3.2. Europe Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.3.2.1. U.K.
5.3.2.1.1. U.K. Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.3.2.2. Germany
5.3.2.2.1. Germany Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.3.2.3. Rest of Europe
5.3.2.3.1. Rest of Europe Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.4. Asia Pacific Cervical Dysplasia Diagnostic Market Analysis, 2015 – 2025
5.4.1. Asia Pacific Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
5.4.2. Asia Pacific Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.4.2.1. Japan
5.4.2.1.1. Japan Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.4.2.2. China
5.4.2.2.1. China Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.4.2.3. Rest of Asia Pacific
5.4.2.3.1. Rest of Asia Pacific Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.5. Latin America Cervical Dysplasia Diagnostic Market Analysis, 2015 – 2025
5.5.1. Latin America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
5.5.2. Latin America Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.5.2.1. Brazil
5.5.2.1.1. Brazil Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.5.2.2. Mexico
5.5.2.2.1. Mexico Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.5.2.3. Rest of Latin America
5.5.2.3.1. Rest of Latin America Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.6. Middle East & Africa (MEA) Cervical Dysplasia Diagnostic Market Analysis, 2015 – 2025
5.6.1. MEA Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
5.6.2. MEA Cervical Dysplasia Diagnostic Market, by Region, 2015 – 2025 (US$ Mn)
5.6.2.1. GCC
5.6.2.1.1. GCC Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.6.2.2. Rest of MEA
5.6.2.2.1. Rest of MEA Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
Chapter 6. Company Profiles
6.1. Abbott Laboratories
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Becton, Dickinson and company
6.3. F. Hoffmann La-Roche Ltd.
6.4. Hologic, Inc.
6.5. Micromedic Technologies Ltd.
6.6. OncoHealth Corporation
6.7. PDS Biotechnology Corporation
6.8. Quest Diagnostics, Inc.
6.9. QIAGEN N.V.
6.10. Other Notable Players
TABLE 1 Global Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Cervical Dysplasia Diagnostic Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 3 North America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 4 U.S. Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 5 Canada Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 8 UK Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 9 Germany Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 10 Rest of Europe Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 13 Japan Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 14 China Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 15 Rest of Asia Pacific Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025(US$ Mn)
TABLE 17 Latin America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025(US$ Mn)
TABLE 18 Brazil Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025(US$ Mn)
TABLE 19 Mexico America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025(US$ Mn)
TABLE 20 Rest of Latin America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025(US$ Mn)
TABLE 21 Latin America Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 23 GCC Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 24 Rest of Middle East and Africa Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 25 Middle East and Africa Cervical Dysplasia Diagnostic Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 26 Abbott Laboratories: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 27 Becton, Dickinson and company: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 28 F. Hoffmann La-Roche Ltd.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 29 Hologic, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 30 Micromedic Technologies Ltd.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 31 OncoHealth Corporation: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 32 PDS Biotechnology Corporation: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 33 Quest Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 34 QIAGEN N.V.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
FIG. 1 Cervical Dysplasia: Market Segmentation
FIG. 2 Global Cervical Dysplasia Diagnostic Market Share, by Type, 2016 (US$ Mn)
FIG. 3 Global Cervical Dysplasia Diagnostic Market, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Global Cervical Dysplasia Diagnostic Market, by HPV Test, 2015 – 2025 (US$ Mn)
FIG. 7 Global Cervical Dysplasia Diagnostic Market, by Pap Smear Test, 2015 – 2025 (US$ Mn)
FIG. 8 Global Cervical Dysplasia Diagnostic Market, by Biopsy, 2015 – 2025 (US$ Mn)
FIG. 9 Global Cervical Dysplasia Diagnostic Market, by Colposcopy, 2015 – 2025 (US$ Mn)
FIG. 10 U.S. Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 11 Canada Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 12 U.K. Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 13 Germany Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 14 Rest of Europe Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 15 Japan Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 16 China Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 17 Rest of Asia Pacific Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 18 Brazil Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 19 Mexico Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 20 Rest of Latin America Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 21 GCC Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest of Middle East and Africa Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)